borderline significanceP = 0.05
Subjects with blood transfusion history had a higher (20/40: 50%) seroprevalence of HEV exposure than those without such clinical characteristic (80/233: 34.3%) (borderline significance: P = 0.05).
Subjects with blood transfusion history had a higher (20/40: 50%) seroprevalence of HEV exposure than those without such clinical characteristic (80/233: 34.3%) (borderline significance: P = 0.05).